Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pneumonia - pathogen-based or constellation-based therapy?].

A Kuhnke1, T Welte, N Suttorp

  • 1Medizinische Klinik mit Schwerpunkt Infektiologie und Pneumologie, Charite, Campus Virchow Klinikum, Augustenburger Platz 1, 13 353 Berlin. antje.kuhnke@charite.de

Der Internist
|June 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.

Respiratory research·2024
Same author

Association between lung function and dyspnoea and its variation in the multinational Burden of Obstructive Lung Disease (BOLD) study.

Pulmonology·2024
Same author

Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONET.

Respiratory research·2024
Same author

Atrial fibrillation and survival on a medical intensive care unit.

International journal of cardiology·2023
Same author

[Management of Adult Community-Acquired Pneumonia and Prevention - Update 2021 - Guideline of the German Respiratory Society (DGP), the Paul-Ehrlich-Society for Chemotherapy (PEG), the German Society for Infectious Diseases (DGI), the German Society of Medical Intensive Care and Emergency Medicine (DGIIN), the German Viological Society (DGV), the Competence Network CAPNETZ, the German College of General Practitioneers and Family Physicians (DEGAM), the German Society for Geriatric Medicine (DGG), the German Palliative Society (DGP), the Austrian Society of Pneumology Society (ÖGP), the Austrian Society for Infectious and Tropical Diseases (ÖGIT), the Swiss Respiratory Society (SGP) and the Swiss Society for Infectious Diseases Society (SSI)].

Pneumologie (Stuttgart, Germany)·2021
Same author

Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade.

Infection·2021
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Community-acquired pneumonia (CAP) requires prompt antibiotic therapy. Treatment choice for CAP must balance suspected pathogens and patient-specific risk factors for improved outcomes.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Context:

  • Community-acquired pneumonia (CAP) is a leading cause of infectious disease morbidity and mortality.
  • Accurate pathogen identification is often delayed at symptom onset.
  • Effective antibiotic selection is critical for patient prognosis.

Purpose:

  • To outline the critical factors influencing initial antibiotic selection for CAP.
  • To emphasize the shift from pathogen-based to constellation-based treatment strategies.

Summary:

  • Early and adequate antibiotic treatment is vital for CAP patients.
  • Antibiotic choice depends on suspected pathogens, local resistance patterns, and individual patient risk factors (age, severity, comorbidities, prior treatment).
  • Treatment should transition from pathogen-based to constellation-based approaches.

Related Experiment Videos

Impact:

  • Optimizing antibiotic selection can improve patient survival rates for CAP.
  • This approach aids clinicians in making informed treatment decisions for CAP.
  • Reduces mortality and morbidity associated with this common infection.